Article
Elevated level of lysophosphatidic acid among patients with HNF1B mutations and its role in RCAD syndrome: a multiomic study.
Metabolomics : Official journal of the Metabolomic Society - 18 Feb 2022
Małachowska Beata, Janikiewicz Justyna, Pietrowska Karolina, Wyka Krystyna, Madzio Joanna, Wypyszczak Kamila, Tkaczyk Marcin, Chrul Sławomir, Zwiech Rafał, Hogendorf Anna, Małecki Maciej T, Borowiec Maciej, Krętowski Adam, Młynarski Wojciech, Dobrzyń Agnieszka, Ciborowski Michał, Fendler Wojciech
Abstract excerpt
INTRODUCTION: Patients with hepatocyte nuclear factor-1 beta (HNF1B) mutations present a variable phenotype with two main symptoms: maturity onset diabetes of the young (MODY) and polycystic kidney disease (PKD). OBJECTIVES: Identification of serum metabolites specific for HNF1Bmut and evaluation of their role in disease pathogenesis. METHODS: We recruited patients with HNF1Bmut (N = 10), HNF1Amut (N = 10), PKD:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
